Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1937 2
1947 1
1973 1
1976 2
1977 1
1978 1
1979 2
1981 1
1985 2
1986 3
1987 2
1988 1
1989 1
1990 2
1991 2
1992 5
1993 3
1994 1
1996 3
1997 3
1998 1
1999 2
2000 5
2001 2
2002 2
2003 3
2004 4
2005 5
2006 10
2007 13
2008 14
2009 10
2010 14
2011 11
2012 15
2013 19
2014 18
2015 22
2016 18
2017 16
2018 30
2019 28
2020 27
2021 34
2022 21
2023 24
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

369 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
Tutt ANJ, Garber JE, Kaufman B, Viale G, Fumagalli D, Rastogi P, Gelber RD, de Azambuja E, Fielding A, Balmaña J, Domchek SM, Gelmon KA, Hollingsworth SJ, Korde LA, Linderholm B, Bandos H, Senkus E, Suga JM, Shao Z, Pippas AW, Nowecki Z, Huzarski T, Ganz PA, Lucas PC, Baker N, Loibl S, McConnell R, Piccart M, Schmutzler R, Steger GG, Costantino JP, Arahmani A, Wolmark N, McFadden E, Karantza V, Lakhani SR, Yothers G, Campbell C, Geyer CE Jr; OlympiA Clinical Trial Steering Committee and Investigators. Tutt ANJ, et al. N Engl J Med. 2021 Jun 24;384(25):2394-2405. doi: 10.1056/NEJMoa2105215. Epub 2021 Jun 3. N Engl J Med. 2021. PMID: 34081848 Free PMC article. Clinical Trial.
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, Wolmark N, Rastogi P, Schneeweiss A, Redondo A, Fischer HH, Jacot W, Conlin AK, Arce-Salinas C, Wapnir IL, Jackisch C, DiGiovanna MP, Fasching PA, Crown JP, Wülfing P, Shao Z, Rota Caremoli E, Wu H, Lam LH, Tesarowski D, Smitt M, Douthwaite H, Singel SM, Geyer CE Jr; KATHERINE Investigators. von Minckwitz G, et al. N Engl J Med. 2019 Feb 14;380(7):617-628. doi: 10.1056/NEJMoa1814017. Epub 2018 Dec 5. N Engl J Med. 2019. PMID: 30516102 Clinical Trial.
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Geyer CE Jr, Garber JE, Gelber RD, Yothers G, Taboada M, Ross L, Rastogi P, Cui K, Arahmani A, Aktan G, Armstrong AC, Arnedos M, Balmaña J, Bergh J, Bliss J, Delaloge S, Domchek SM, Eisen A, Elsafy F, Fein LE, Fielding A, Ford JM, Friedman S, Gelmon KA, Gianni L, Gnant M, Hollingsworth SJ, Im SA, Jager A, Jóhannsson ÓÞ, Lakhani SR, Janni W, Linderholm B, Liu TW, Loman N, Korde L, Loibl S, Lucas PC, Marmé F, Martinez de Dueñas E, McConnell R, Phillips KA, Piccart M, Rossi G, Schmutzler R, Senkus E, Shao Z, Sharma P, Singer CF, Španić T, Stickeler E, Toi M, Traina TA, Viale G, Zoppoli G, Park YH, Yerushalmi R, Yang H, Pang D, Jung KH, Mailliez A, Fan Z, Tennevet I, Zhang J, Nagy T, Sonke GS, Sun Q, Parton M, Colleoni MA, Schmidt M, Brufsky AM, Razaq W, Kaufman B, Cameron D, Campbell C, Tutt ANJ; OlympiA Clinical Trial Steering Committee and Investigators. Geyer CE Jr, et al. Ann Oncol. 2022 Dec;33(12):1250-1268. doi: 10.1016/j.annonc.2022.09.159. Epub 2022 Oct 10. Ann Oncol. 2022. PMID: 36228963 Free PMC article. Clinical Trial.
Methylprednisolone for Heart Surgery in Infants - A Randomized, Controlled Trial.
Hill KD, Kannankeril PJ, Jacobs JP, Baldwin HS, Jacobs ML, O'Brien SM, Bichel DP, Graham EM, Blasiole B, Resheidat A, Husain AS, Kumar SR, Kirchner JL, Gallup DS, Turek JW, Bleiweis M, Mettler B, Benscoter A, Wald E, Karamlou T, Van Bergen AH, Overman D, Eghtesady P, Butts R, Kim JS, Scott JP, Anderson BR, Swartz MF, McConnell PI, Vener DF, Li JS; STRESS Network Investigators. Hill KD, et al. N Engl J Med. 2022 Dec 8;387(23):2138-2149. doi: 10.1056/NEJMoa2212667. Epub 2022 Nov 6. N Engl J Med. 2022. PMID: 36342116 Free PMC article. Clinical Trial.
CPT-Symmetric Universe.
Boyle L, Finn K, Turok N. Boyle L, et al. Phys Rev Lett. 2018 Dec 21;121(25):251301. doi: 10.1103/PhysRevLett.121.251301. Phys Rev Lett. 2018. PMID: 30608856
The Ins and Outs of TAPBPR.
Ilca T, Boyle LH. Ilca T, et al. Among authors: boyle lh. Curr Opin Immunol. 2020 Jun;64:146-151. doi: 10.1016/j.coi.2020.06.004. Epub 2020 Aug 16. Curr Opin Immunol. 2020. PMID: 32814254 Review.
Properties of the tapasin homologue TAPBPR.
Neerincx A, Boyle LH. Neerincx A, et al. Among authors: boyle lh. Curr Opin Immunol. 2017 Jun;46:97-102. doi: 10.1016/j.coi.2017.04.008. Epub 2017 May 18. Curr Opin Immunol. 2017. PMID: 28528220 Review.
Selective sweeps in SARS-CoV-2 variant competition.
Boyle L, Hletko S, Huang J, Lee J, Pallod G, Tung HR, Durrett R. Boyle L, et al. Proc Natl Acad Sci U S A. 2022 Nov 22;119(47):e2213879119. doi: 10.1073/pnas.2213879119. Epub 2022 Nov 3. Proc Natl Acad Sci U S A. 2022. PMID: 36383746 Free PMC article.
The challenges of dementia care in rural China.
Chen S, Boyle LL, Conwell Y, Xiao S, Chiu HF. Chen S, et al. Among authors: boyle ll. Int Psychogeriatr. 2014 Jul;26(7):1059-64. doi: 10.1017/S1041610214000854. Epub 2014 May 20. Int Psychogeriatr. 2014. PMID: 24846782 Free PMC article. No abstract available.
369 results